Position in JNJ
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$2,571,700
+$94,546 QoQ
Shares Held
10,126
-0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.65%
of 13F equity value
Holder Rank
#2,134
of 4,676 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bank & Trust Co holds $22,231,590 across 12 Drug Manufacturers - General names. JNJ ranks #2 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,001 | $13,194,930 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
10,126 | $2,571,700 | |
| 3 | MRK |
Merck & Co., Inc.
|
14,439 | $1,855,411 | |
| 4 | ABBV |
AbbVie Inc.
|
5,923 | $1,490,463 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,387 | $1,174,698 | |
| 6 | PFE |
Pfizer Inc
|
40,931 | $985,618 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,090 | $769,410 | |
| 8 | GSK |
GSK plc
|
1,879 | $98,497 |
All Filings in JNJ
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,571,700 | 10,126 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $2,477,154 | 10,134 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2,109,027 | 10,191 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $1,889,615 | 10,191 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $1,556,675 | 10,191 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,667,852 | 10,057 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,457,769 | 10,080 | Shares | Sole | 2025-01-07 | |
| 2024-09-30 | $1,642,478 | 10,135 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $1,473,877 | 10,084 | Shares | Sole | 2024-07-08 | |
| No filing history on record for this holder in this stock. | ||||||